|A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease||
||139||All||18 Years and older (Adult, Senior)||NCT00615199||A3921043||January 2008||October 2009||October 2009||February 14, 2008||January 25, 2013||December 31, 2012||
|2||NCT02535689||Recruiting||Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus||
||38||All||18 Years to 100 Years (Adult, Senior)||NCT02535689||150185
|August 28, 2015||May 20, 2020||May 20, 2020||August 31, 2015||October 27, 2017||
† Study has passed its completion date and status has not been verified in more than two years.